Skip to main content
. 2015 Feb 7;6(9):7040–7052. doi: 10.18632/oncotarget.3140

Figure 3. Effects of chemotherapy on Ki67 and p21 expression in breast tumor cell lines.

Figure 3

(A) Ki67 is heterogeneously expressed in breast tumor cell lines in response to doxorubicin (100 nM). (B) p21 is variably expressed among breast tumor cell lines following treatment with doxorubicin (100 nM).